Research Analysts at Leerink Swann Maintained their Buy rating for Evolent Health (EVH). The Price Target is $25.0; Camden Asset Management LP Lowered Dominion Energy (DCUC) Stake By $103.23 Million

November 19, 2017 - By Hazel Jackson

Camden Asset Management LP decreased Dominion Energy Inc (DCUC) stake by 49.65% reported in 2017Q2 SEC filing. Camden Asset Management LP sold 2.15M shares as Dominion Energy Inc (DCUC)’s stock 0.00%. The Camden Asset Management LP holds 2.18 million shares with $104.77 million value, down from 4.33 million last quarter. Dominion Energy Inc now has $956.00 million valuation. It closed at $47.8 lastly. It is down 0.00% since November 19, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 14 analysts covering Evolent Health (NYSE:EVH), 14 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Evolent Health has $3500 highest and $16.0 lowest target. $27’s average target is 142.15% above currents $11.15 stock price. Evolent Health had 32 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was reinitiated by JP Morgan on Friday, October 28 with “Overweight”. Robert W. Baird maintained Evolent Health Inc (NYSE:EVH) rating on Wednesday, June 14. Robert W. Baird has “Buy” rating and $3500 target. The firm has “Buy” rating by Canaccord Genuity given on Wednesday, January 6. The company was maintained on Thursday, September 28 by Robert W. Baird. FBR Capital maintained the shares of EVH in report on Friday, August 5 with “Outperform” rating. The firm has “Buy” rating by Cantor Fitzgerald given on Friday, November 10. Oppenheimer maintained it with “Buy” rating and $2800 target in Tuesday, August 8 report. JP Morgan maintained Evolent Health Inc (NYSE:EVH) rating on Monday, March 14. JP Morgan has “Overweight” rating and $19 target. The firm has “Buy” rating by Jefferies given on Thursday, September 28. Robert W. Baird maintained it with “Buy” rating and $35.0 target in Sunday, September 24 report.

The stock increased 0.68% or $0.07 on November 17, reaching $11.15. About 1.28 million shares traded. Evolent Health Inc (NYSE:EVH) has risen 80.60% since November 19, 2016 and is uptrending. It has outperformed by 63.90% the S&P500.

Analysts await Evolent Health Inc (NYSE:EVH) to report earnings on February, 27. They expect $-0.04 EPS, up 88.57% or $0.31 from last year’s $-0.35 per share. After $-0.04 actual EPS reported by Evolent Health Inc for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Evolent Health, Inc. is engaged in healthcare delivery and payment. The company has market cap of $862.31 million. The Firm supports health systems and physician organizations in their migration toward value care and population health management. It currently has negative earnings. The Firm provides an end-to-end, technology-enabled services platform for providers.

Camden Asset Management LP increased Ani Pharmaceuticals Inc (Prn) stake by 700,000 shares to 2.03 million valued at $2.13M in 2017Q2. It also upped Bottomline Tech Del Inc (Prn) stake by 2.04 million shares and now owns 49.68 million shares. Csg Sys Intl Inc (Prn) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com